Dina Oster, MD
Hospitalist · Palm Harbor, FLNPI 1518071356
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $906 and has fallen 57.5% since, to $386 in 2025. Among hospitalist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$513
- AbbVie$452
- AstraZeneca$424
- Amgen$255
- Pfizer$220
- Lilly USA, LLC$151
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $513 |
| AbbVie | 23 | $452 |
| AstraZeneca | 26 | $424 |
| Amgen | 9 | $255 |
| Pfizer | 13 | $220 |
| Lilly USA, LLC | 9 | $151 |
| Merck | 9 | $145 |
| Exact Sciences | 6 | $99 |
| Abbott | 5 | $99 |
| GSK | 4 | $83 |
| Boehringer Ingelheim | 3 | $68 |
| Sanofi-aventis U.S. LLC | 3 | $65 |
| Dynavax Technologies Corporation | 3 | $62 |
| Bayer | 3 | $55 |
| Shield Therapeutics Inc | 3 | $54 |
| Johnson & Johnson | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Boston Scientific | 2 | $33 |
| Topcon Healthcare Solutions, Inc. | 1 | $33 |
| Amarin Pharma, Inc. | 2 | $28 |
| Corcept Therapeutics | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$121
How this compares
$3,056 in reported general payments places this provider in the 95th percentile of 1,570 hospitalist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $82,410 |
| FarxigaDapagliflozin Propanediol | 64 | $80,669 |
| EliquisApixaban | 40 | $43,822 |
| MounjaroTirzepatide | 24 | $33,479 |
| JardianceEmpagliflozin | 23 | $30,019 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $19,720 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 32 | $19,188 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $16,733 |
| LinzessLinaclotide | 17 | $15,100 |
| Repatha SureclickEvolocumab | 15 | $12,562 |
| Icosapent Ethyl | 13 | $3,466 |
| Rosuvastatin Calcium | 233 | $3,213 |
| Bupropion XlBupropion Hcl | 76 | $2,723 |
| Atorvastatin Calcium | 321 | $2,660 |
| Advair DiskusFluticasone Propion/Salmeterol | 12 | $2,370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $424 | $97,40380 claims |
| Novo NordiskOzempic | $513 | $82,41080 claims |
| PfizerEliquis | $220 | $43,82240 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $83 | $38,90855 claims |
| Lilly USA, LLCMounjaro | $151 | $33,47924 claims |
| Boehringer IngelheimJardiance | $68 | $30,01923 claims |
| AbbVieLinzess, Synthroid | $452 | $16,31529 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $14 | $76411 claims |
| Sanofi-aventis U.S. LLCLantus | $65 | $75911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,570 hospitalist providers in Florida.
Other hospitalist in Palm Harbor
- Murray EpsteinMiami$370K
- Oliver AbelaFort Myers$77K
- Joshua LenchusFort Lauderdale$73K
- Tuncay TaskesenThe Villages$22K
- Diego MunozApopka$17K
- Francisco Perez LoretoMiami$17K
- Tereese AllenTampa$11K
- Timothy LongBay Pines$10K
- Iahn GonsenhauserFort Myers$8K
- Michael ShehataRiverview$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.